Progenics Pharmaceuticals INC
SEC CIK 835887 · PGNX · last insider filing 2020-06-23
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Campbell Bradley L | Director | filed 2016 - 2020 |
| Ende Eric J | Director | filed 2019 - 2020 |
| Ferrante Karen Jean | Director | filed 2014 - 2020 |
| Macdougall Ann L. | Director | filed 2019 - 2020 |
| Ber Gerard | Director | filed 2019 - 2020 |
| Maeusli Heinz Christoph | Director | filed 2019 - 2020 |
| Mims David W. | Director · Interim CEO and Interim CFO | filed 2019 - 2020 |
| Kishbauch Michael D | Director | filed 2013 - 2019 |
| Williams Nicole | Director | filed 2007 - 2019 |
| Scheinberg David A | Director | filed 2006 - 2019 |
| Crowley Peter J | Director | filed 2009 - 2019 |
| Baker Mark Robert | Director · President | filed 2006 - 2019 |
| Maddon Paul J | Director · Chief Executive Officer/CSO | filed 2006 - 2016 |
| Goff Stephen P | Director | filed 2006 - 2013 |
| Baker Charles A | Director | filed 2006 - 2012 |
| Briner Kurt W | Director | filed 2007 - 2012 |
| Dalton Mark F | Director | filed 2006 - 2011 |
| Jacobson Paul F | Director | filed 2007 - 2008 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Wong Vivien | Executive Vice President | filed 2015 - 2020 |
| Tenbarge Bryce | Vice President, Commercial | filed 2016 - 2020 |
| Das Asha | Chief Medical Officer | filed 2019 - 2020 |
| Osorio Benedict | Senior Vice President, Quality | filed 2018 - 2020 |
| Fabbio Patrick | CFO | filed 2015 - 2020 |
| Summer Jeffery | Senior VP, Strategy and Perfor | filed 2016 - 2018 |
| Hirt Sheldon | Executive VP & General Counsel | filed 2015 - 2016 |
| Israel Robert J | Sr. VP, Medical Affairs | filed 2006 - 2015 |
| Lovallo Angelo William JR | Vice President Finance | filed 2013 - 2015 |
| Youssoufian Hagop | Executive Vice President R&D | filed 2013 - 2014 |
| Olson William C | VP, Research & Development | filed 2006 - 2013 |
| Mckinney Robert A | Senior VP, CFO | filed 2006 - 2012 |
| Boyd Thomas A | Sr. VP, Product Dev. | filed 2006 - 2010 |
| Kremer Alton B | VP, Clinical Research | filed 2006 - 2008 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.